Concepedia

Publication | Open Access

KRAS G13D Mutation and Sensitivity to Cetuximab or Panitumumab in a Colorectal Cancer Cell Line Model.

Full Paper Access

56

Citations

16

References

2014

Year

Shalini Sree Kumar, Timothy Price, Omar Mohyieldin, Matthew Borg, Amanda Townsend, Jennifer E. Hardingham
PubMed

Abstract

The specific KRAS mutation determines the responsiveness to anti-EGFR monoclonal antibody treatment, corresponding to reported clinical observations.

References

YearCitations

Page 1